A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
ITEM 1. BUSINESS Hypha Labs, Inc. was incorporated in Nevada on October 5, 2010. Hypha Labs, Inc. and its subsidiaries (“Hypha Labs,” the “Company,” “we,” “our” or “us”) was a service-oriented independent testing laboratory, data analytics and media firm focused on the developing cannabis and hemp markets, and supported the cannabis industry’s best practices for reliable testing. Our mission was to provide pharmaceutical-grade analysis and testing to the cannabis industry, under ISO-17025:2017 guidelines, to ensure consumers and patients know exactly what was in the cannabis they ingest and to help maximize the quality of our clients’ products through research, development, and standardization. Hypha Labs had been operating a cannabis-testing lab in Nevada since 2015. On February 20, 2024, we completed the sale of the net assets of our wholly owned subsidiary Digipath Labs, Inc. (“Digipath Labs”).
| Metric | TTM | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 2.7M | 2.5M | 2.6M | 2.6M | 2.8M |
| Net Income | -2.3M | -2.2M | -687K | -2.3M | -1.8M | -1.7M |
| EPS | $-0.01 | $-0.03 | $-0.01 | $-0.04 | $-0.04 | $-0.04 |
| Free Cash Flow | 0 | -203K | -192K | -813K | -1.1M | -371K |
| ROIC | -438.0% | -67.8% | -32.3% | -96.8% | -228.6% | -136.9% |
| Gross Margin | - | 39.5% | 28.6% | 30.9% | 32.9% | 27.1% |
| Debt/Equity | 0.00 | -0.55 | -0.76 | -0.85 | 2.02 | 0.38 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | -2.2M | -1.2M | -772K | -2.2M | -1.8M | -1.8M |
| Operating Margin | 0.0% | -42.6% | -30.9% | -85.2% | -72.2% | -61.9% |
| ROE | 0.0% | - | - | - | -423.9% | -163.0% |
| Shares Outstanding | 163M | 75M | 69M | 58M | 45M | 41M |
Hypha Labs, Inc. passes 1 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average gross margin is 31.8%. At current prices, the estimated annualized return to fair value is +0.0%.
Hypha Labs, Inc. (FUNI) has a 5-year average return on invested capital (ROIC) of -83.5%. This is below average and may indicate limited pricing power.
Hypha Labs, Inc. (FUNI) has a market capitalization of $4M. It is classified as a small-cap stock.
Hypha Labs, Inc. (FUNI) does not currently pay a regular dividend.
Hypha Labs, Inc. (FUNI) operates in the Services-Testing Laboratories industry, within the Industrials sector.
Hypha Labs, Inc. (FUNI) reported annual revenue of $3 million in its most recent fiscal year, based on SEC EDGAR filings.
Hypha Labs, Inc. (FUNI) has a net profit margin of -83.3%. The company is currently unprofitable.
Hypha Labs, Inc. (FUNI) generated $-203 thousand in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
Hypha Labs, Inc. (FUNI) reported earnings per share (EPS) of $-0.03 in its most recent fiscal year.
Hypha Labs, Inc. (FUNI) has a 5-year average gross margin of 31.8%. This indicates decent pricing power.
The Ledger Terminal provides 12 years of financial data for Hypha Labs, Inc. (FUNI), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Hypha Labs, Inc. (FUNI) has a book value per share of $-0.04, based on its most recent annual SEC filing.
No recent press releases.